Latest filing published 13 May 2011 for INTERMUNE INC.
First 200 filings with a declared amount
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Warburg Pincus Equity Partners LP is a declared insider at 5 companies; the most frequent names are Zymogenetics Inc, Viracta Therapeutics, Inc. and ev3 Inc. Between 17 March 2006 and 11 May 2011, the trades on record add up to 245 filings.
On the open market, the record shows 232 purchases worth €34.2M and 8 sales worth €84.1M. Netting one side against the other leaves €50.0M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
In size, the median ticket on the buying side is €15k.
The latest filing, published on 13 May 2011, reports a transaction in Intermune Inc. The last insider purchase was made public on 27 January 2010, 6,113 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 245 declarations